MiR-548-3p functions as an anti-oncogenic regulator in breast cancer

Biomedicine and Pharmacotherapy

Volumn 75, Issue , 2015, Pages 111-116

  Shi, Yafei ^a   Qiu, Min ^a   Wu, Yanyan ^a   Hai, Lu ^a  

^a JINING MEDICAL UNIVERSITY   (China)

Author keywords

Breast cancer; ECHS1; MicroRNAs; MiR 548 3p

Indexed keywords

CASPASE 3; CASPASE 7; ENOYL COENZYME A HYDRATASE SHORT CHAIN 1; MICRORNA; MICRORNA 548 3P; PROTEIN; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; ENOYL COA HYDRATASE, SHORT CHAIN, 1, MITOCHONDRIAL, HUMAN; ENOYL COENZYME A HYDRATASE; MIRN548 MICRORNA, HUMAN;

3' UNTRANSLATED REGION; APOPTOSIS; ARTICLE; BREAST CANCER; BREAST CANCER CELL LINE; CANCER GROWTH; CANCER INHIBITION; CELL FUNCTION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; ENZYME REGULATION; GENE OVEREXPRESSION; GENE TARGETING; GENETIC TRANSFECTION; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; UPREGULATION; BINDING SITE; BREAST TUMOR; FEMALE; GENE EXPRESSION REGULATION; GENETICS; MCF-7 CELL LINE; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION; TIME FACTOR;

3' UNTRANSLATED REGIONS; APOPTOSIS; BINDING SITES; BREAST NEOPLASMS; CELL PROLIFERATION; DOWN-REGULATION; ENOYL-COA HYDRATASE; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MCF-7 CELLS; MICRORNAS; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSFECTION;

EID: 84944165367     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2015.07.027     Document Type: Article

References (15)

1. Chavez-MacGregor M., Gonzalez-Angulo A.M. Breast cancer in New drugs, new knowledge, new targets. Nat. Rev. 2012, 10(2):75-76.
2. Yamaguchi M., Kwong Y.L., Kim W.S., Maeda Y., Hashimoto C., Suh C., Izutsu K., Ishida F., Isobe Y., Sueoka et al E. Phase II. Study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)/T-cell lymphoma, nasal type: the NK-Cell tumor study group study. J. Clin. Oncol. 2015, 29(33):4410-4416.
3. Tahiri A., Leivonen S.K., Luders T., Steinfeld I., Ragle Aure M., Geisler J., Makela R., Nord S., Riis M.L., Yakhini Z., et al. Deregulation of cancer-related miRNAs is a common event in both benign and malignant human breast tumors. Carcinogenesis 2015, 35(1):76-85.
4. Fu P., Du F., Yao M., Lv K., Liu Y. MicroRNA-185 inhibits proliferation by targeting c-Met in human breast cancer cells. Exp. Ther. Med. 2015, 8(6):1879-1883.
5. T. Isobe, S. Hisamori, D.J. Hogan, M. Zabala, D.G. Hendrickson, P. Dalerba, S. Cai, F. Scheeren, A.H. Kuo, S.S. Sikandar, et al., miR-142 regulates the tumorigenicity of human breast cancer stem cells through the canonical WNT signaling pathway eLife 3.
6. Mar-Aguilar F., Luna-Aguirre C.M., Moreno-Rocha J.C., Araiza-Chavez J., Trevino V., Rodriguez-Padilla C., Resendez-Perez D. Differential expression of miR-21, miR-125b and miR-191 in breast cancer tissue. Asia-Pac. J. Clin. Oncol. 2015, 9(1):53-59.
7. Scott G.K., Goga A., Bhaumik D., Berger C.E., Sullivan C.S., Benz C.C. Coordinate suppression of ERBB2 and ERBB3 by enforced expression of micro-RNA miR-125a or miR-125b. J. Biol. Chem. 2007, 282(2):1479-1486.
8. Khokhar A., Noorali S., Sheraz M., Mahalingham K., Pace D.G., Khanani M.R., Bagasra O. Computational analysis to predict functional role of hsa-miR-3065-3p as an antiviral therapeutic agent for treatment of triple infections: HCV, HIV-1, and HBV. Libyan J. Med. 2015, 7:19774.
9. Maltseva D.V., Galatenko V.V., Samatov T.R., Zhikrivetskaya S.O., Khaustova N.A., Nechaev I.N., Shkurnikov M.U., Lebedev A.E., Mityakina I.A., Kaprin A.D., et al. MiRNome of inflammatory breast cancer. BMC Res. Notes 2015, 7:871.
10. van Kouwenhove M., Kedde M., Agami R. MicroRNA regulation by RNA-binding proteins and its implications for cancer. Nat. Rev. Cancer 2015, 11(9):644-656.
11. Hu B., Ying X., Wang J., Piriyapongsa J., Jordan I.K., Sheng J., Yu F., Zhao P., Li Y., Wang H., et al. Identification of a tumor-suppressive human-specific microRNA within the FHIT tumor-suppressor gene. Cancer Res. 2015, 74(8):2283-2294.
12. Jiang L., He D., Yang D., Chen Z., Pan Q., Mao A., Cai Y., Li X., Xing H., Shi M., et al. MiR-489 regulates chemoresistance in breast cancer via epithelial mesenchymal transition pathway. FEBS Lett. 2015, 588(11):2009-2015.
13. Zhu X.S., Dai Y.C., Chen Z.X., Xie J.P., Zeng W., Lin Y.Y., Tan Q.H. Knockdown of ECHS1 protein expression inhibits hepatocellular carcinoma cell proliferation via suppression of Akt activity. Crit. Rev. Eukaryotic Gene Exp. 2015, 23(3):275-282.
14. Liu X., Feng R., Du L. The role of enoyl-CoA hydratase short chain 1 and peroxiredoxin 3 in PP2-induced apoptosis in human breast cancer MCF-7 cells. FEBS Lett. 2015, 584(14):3185-3192.
15. Piriyapongsa J., Jordan I.K. A family of human microRNA genes from miniature inverted-repeat transposable elements. PloS One 2007, 2(2):e203.